Corporate News - Beijing Beilu Pharmaceutical Co., Ltd.

Hichi Pharmaceutical's Iodixanol API Approved for Market

2024/09/09

Iodixanol is the active pharmaceutical ingredient for iodixanol injection, a contrast agent used for intrathecal contrast, cardiovascular angiography, and intravenous urography. Its mechanism of actio...

VIEW_MORE

【New Product】Approval of Gadopentetate Dimeglumine Injection and Chemical Raw Materials by Beilu Pharmaceutical

2024/07/11

Recently, Beilu Pharmaceuticals received the Drug Registration Certificate for Gadopentetate Dimeglumine Injection and the approval notice for the marketing application of Gadopentetate Dimeglumine as...

VIEW_MORE

Beilu Pharmaceutical Once Again Honored as "Advanced Unit for Routine Monitoring of Adverse Drug Reactions in Beijing"

2024/07/09

Recently, the Beijing Municipal Drug Administration and the Beijing Municipal Health Commission released a "Notification on Units and Individuals with Outstanding Performance in Drug, Medical Dev...

VIEW_MORE

New Product: Approval Granted for Beilu Pharmaceutical's Enteric-coated Prolonged-release Paroxetine Hydrochloride Tablets

2024/05/10

Recently, Beilu Pharmaceutical received a Drug Registration Certificate from the National Medical Products Administration for Paroxetine Hydrochloride Enteric-Coated Sustained-Release Tablets with a s...

VIEW_MORE

CPHI China 2024 Invitation

2024/04/23

VIEW_MORE

Beilu Pharmaceutical Officially Acquires Tianyuan Pharmaceutical, Continues to Advance the Strategic Layout of Traditional Chinese Medicine

2024/04/16

In recent days, Beilu Pharmaceutical has disclosed the "Announcement on the Acquisition of 80% Equity Interest in Chengde Tianyuan Pharmaceutical Co., Ltd.".The Acquisition Is Progressing Sm...

VIEW_MORE

Beilu Pharmaceutical's Gadobenate Dimeglumine Injection Passes Generic Drug Consistency Evaluation!

2024/03/22

Recently, Beilu Pharmaceutical received the "Drug Supplementary Application Approval Notice" (Notice Number: 2024B01144) for Gadobenate Dimeglumine Injection issued by the National Medical P...

VIEW_MORE